Renata PLC: Clinical Trials

1 trial sponsored by Renata PLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Renata PLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
Eltrombopag 25 MG, Prednisolone - Primary Immune Thrombocytopenia
Phase 1 / Phase 2RecruitingRenata PLC1002025-02-072025-02-18

Conditions studied

Purpura, Thrombocytopenic, Idiopathic (1)

Interventions

Prednisolone (1)  ·  eltrombopag (1)

Countries

Bangladesh (1)

Top investigators

Md Manirul Islam, MBBS,FCPS (1)

Results publications

PMID 19846889, PMID 24802773, PMID 29270980, PMID 30344993, PMID 34452956